Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02223364 · ClinicalTrials.gov registry record · Phase 4
Peripheral Nerve Blocks vs Periarticular Local Anesthetic Injection for Total Knee Arthroplasty (TKA)
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 165
- Enrollment target
NCT02223364: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT02223364 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 165 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02223364, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 165 participants
- Enrollment target
Study Summary
The purpose of this study is to find a better way to make patients comfortable after their knee surgery. The investigators compared three ways of providing pain relief, either by use of a nerve block at the femoral and sciatic nerve areas, or with actual injections in the surgical joint area with one of two different medicines, either ropivacaine or liposomal bupivacaine (Exparel®). The hypothesis was that the nerve block at the femoral and sciatic nerve areas would result in lower pain scores and opioid consumption than either of the two injections in the surgical joint area.
Interventions
- DRUG Peripheral nerve blocks with Bupivacaine
- DRUG Intra articular injection with Ropivacaine
- DRUG Intra articular injection with liposomal bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02223364
The ClinicalTrials.gov registry entry for NCT02223364 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Peripheral nerve blocks with Bupivacaine is the first listed.
NCT02223364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02223364 about?
NCT02223364 is a clinical study titled "Peripheral Nerve Blocks vs Periarticular Local Anesthetic Injection for Total Knee Arthroplasty (TKA)". The purpose of this study is to find a better way to make patients comfortable after their knee surgery. The investigators compared three ways of providing pain relief, either by use of a nerve block at the femoral and sciatic nerve areas, or with actual injections in the surgical joint area with on...
What is the current status of trial NCT02223364?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 165 participants. The study started on 2014-07. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02223364?
The interventions under investigation include: Peripheral nerve blocks with Bupivacaine (DRUG), Intra articular injection with Ropivacaine (DRUG), Intra articular injection with liposomal bupivacaine (DRUG).
Who is sponsoring clinical trial NCT02223364?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.